Date |
Company |
Amount |
Funding type |
Investors |
Therapeutic area |
Type of Information |
2014-07-22 |
Trianta Immunotherapies, a Medigene subsidiary (Germany) |
|
grant |
German Research Foundation (DFG) (Germany) |
Cancer - Oncology |
Grant |
2014-07-21 |
Celsion (USA - NJ) |
$1 million |
grant |
National Institutes of Health\'s Center for Biomedical Imaging and Bioengineering (NIBIB) (USA) |
Cancer - Oncology |
Grant |
2014-07-17 |
BioAlliance Pharma (France) |
€10 million |
loan |
Financière de la Montagne (France) |
Cancer - Oncology - Rare diseases |
Loan |
2014-07-17 |
Bone Therapeutics (Belgium) Image Analysis (UK) SIRRIS (Belgium) |
€576,000 |
grant |
M-ERA.net |
Bone diseases - Regenerative medicine |
Grant |
2014-07-17 |
Paion (Germany) |
€ 4 million |
private placement |
Pharmascience International, Pendopharm\'s affiliate (Canada) |
|
Private placement |
2014-07-16 |
Immatics (Germany) |
€34 million |
Series D financing round |
dievini Hopp Biotech (Germany), Wellington Partners (USA), MIG-advised funds, AT Impf GmbH (Germany) |
Cancer - Oncology |
Series D financing round |
2014-07-16 |
Oncobiologics (USA - NJ) |
undisclosed |
|
Strides Arcolab (India) |
|
Establishment of a new subsidiary in the EU |
2014-07-15 |
amcure (Germany) |
€ 5 million |
series A financing round and grant |
LBBW Venture Capital (Germany), KfW (Germany), MBG Mittelstaendische Beteiligungsgesellschaft Baden-Wuerttemberg (Germany), S-Kap Beteiligungen Pforzheim (Germany), BioM AG (Germany), private investors, German Ministry of Education and Research (BMBF) (Germany) |
Cancer - Oncology |
Series A financing round |
2014-07-15 |
Medigene (Germany) |
€ 15.9 million |
capital increase |
|
Cancer - Oncology |
Capital increase |
2014-07-09 |
Domainex (UK) |
£1.4 million (€1.76 million) |
grant |
Biomedical Catalyst Fund (UK) |
Inflammatory diseases - Respiratory diseases |
Grant |
2014-07-08 |
Argen-X (Belgium - The Netherlands) |
€ 40 million |
IPO |
corporate and institutional investors in Europe and USA, Belgian retail investors, Shire (UK - USA) |
Cancer - Oncology - Autoimmune diseases |
IPO |
2014-07-08 |
Biotie Therapies (Finland) |
$2 million |
grant |
The Michael J. Fox Foundation - MJFF (USA) |
Neurodegenerative diseases |
Grant |
2014-07-08 |
Sophia Genetics (Switzerland) |
$13.75 million (€ 10.1 million) |
series B financing round |
Invoke Capital (UK - USA), Endeavour Vision (Switzerland), Swisscom (Switzerland) |
Genetic diseases |
Series B financing round |
2014-07-08 |
Cynapsus Therapeutics (Canada) |
$0.5 million |
grant |
The Michael J. Fox Foundation - MJFF (USA) |
Neurodegenerative diseases |
Grant |
2014-07-08 |
Bluebird Bio (USA - MA) |
$95.6 million |
IPO |
|
Rare diseases |
IPO |
2014-07-07 |
Abzena (UK) |
£20 million (€25.2 million) |
IPO |
|
Technology - Services |
IPO |
2014-07-04 |
C4X Discovery (UK) |
£1.48 million (€1.86 million) |
grant |
Biomedical Catalyst Fund (UK) |
Metabolic diseases |
Grant |
2014-07-04 |
Galapagos (Belgium) |
€1.9 million |
warrant exercises |
Galapagos\' employee |
|
Capital increase |
2014-07-03 |
TxCell (France) Gene and Cell therapy Unit, Nice (UTCG) (France) Biosafe (Switzerland) |
€ 417,000 |
grant |
Conseil Régional Provence-Alpes-Côte-D’azur (France) |
Autoimmune diseases - Inflammatory diseases |
Grant |
2014-07-03 |
Oasmia Pharmaceutical (Sweden) |
SEK 50 million (€5.46 million) |
private placement |
international institutional investors and qualified investors in Sweden |
Cancer - Oncology |
Private placement |